Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Chemotherapy. Immunotherapy. Tampere University Hospital, Tampere, Finland



Survival: 7.2 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
Immunotherapy
   
Drugs:
Country: Finland
   
City/State/Province: Tampere
   
Hospital: Tampere University Hospital
   
Journal: Link
   
Date: 5/2009

Description:
Patients:
This study involved 22 metastatic melanoma patients with a median age of 56 years; 50% were male.

Treatment:
Patients were treated with the chemotherapy agents carboplatin and vinorelbine in addition to the immune therapy agent interleukin-2 (IL-2), which strengthens the immune response.

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia, thrombocytopenia, and gastrointestinal bleeding. Grade 3-4 fatigue, constipation, and infection were also reported.

Results:
The median overall survival was 7.2 months.

Correspondence: Dr. Meri-Sisko Vuoristo; email: meri-sisko.vuoristo@fimnet.fi

E-mail to a Friend Email Physician More Information